What is Emergent BioSolutions 6-1 Month Momentum %?
6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-04-29), Emergent BioSolutions's 6-1 Month Momentum % is 13.49%.
The industry rank for Emergent BioSolutions's 6-1 Month Momentum % or its related term are showing as below:
EBS's 6-1 Month Momentum % is ranked better than 63.46% of 1114
companies
in the Drug Manufacturers industry
Industry Median: 3.47
vs EBS: 13.49
Competitive Comparison of Emergent BioSolutions's 6-1 Month Momentum %
For the Drug Manufacturers - Specialty & Generic subindustry, Emergent BioSolutions's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Emergent BioSolutions's 6-1 Month Momentum % Distribution in the Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Emergent BioSolutions's 6-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where Emergent BioSolutions's 6-1 Month Momentum % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
Emergent BioSolutions 6-1 Month Momentum % Related Terms
Thank you for viewing the detailed overview of Emergent BioSolutions's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.
Emergent BioSolutions (Emergent BioSolutions) Business Description
Emergent BioSolutions Inc offers public health products to the government and healthcare providers. The company has four main units: vaccines, which produces specialty vaccines for public health threats; devices, such as nasal sprays, skin lotions, and injections; therapeutics, which includes antibody-based treatments; and contract development and manufacturing, which brings treatments to market through collaboration with the pharmaceutical and biotechnology industries and the United States government. Most revenue comes from U.S. government purchases of vaccines, devices, and therapeutic products. The company operates in two reportable segments; the Products Segment and the Services Segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
EBS has been successfully added to your